argenx SE (ARGX) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
ARGX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, argenx SE (ARGX) trades at a price-to-earnings ratio of 40.1x, with a stock price of $787.31 and trailing twelve-month earnings per share of $29.51.
The current P/E is 23% below its 5-year average of 51.9x. Over the past five years, ARGX's P/E has ranged from a low of 26.9x to a high of 92.2x, placing the current valuation at the 67th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, ARGX trades at a 80% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, ARGX commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARGX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ARGX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $39B | 127.0 | - | +207% | |
| $10B | 30.1 | - | -19% | |
| $4B | 9.9Lowest | - | +68% | |
| $108B | 27.7 | 3.35 | +837%Best | |
| $8B | 25.5 | 1.11Best | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ARGX Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $840.95 | $31.24 | 26.9x | -48% |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $551.22 | $15.07 | 36.6x | -30% |
| FY2024 Q4 | $615.00 | $6.67 | 92.2x | +78% |
Average P/E for displayed period: 51.9x
Full ARGX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ARGX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARGX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARGX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARGX — Frequently Asked Questions
Quick answers to the most common questions about buying ARGX stock.
Is ARGX stock overvalued or undervalued?
ARGX trades at 40.1x P/E, below its 5-year average of 51.9x. At the 67th percentile of historical range, the stock is priced at a discount to its own history.
How does ARGX's valuation compare to peers?
argenx SE P/E of 40.1x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is ARGX's PEG ratio?
ARGX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.